
|

| |
Track the *RXSTM Index |
 |
|
 | Stem Cell Stocks (*RXSTM) |
| |
Stem Cell Ideas |
|
|
|
Stem Cell Performance |
|
|
|
Stem Cell Community |
|
| |
|
Index Description: These companies have significant exposure to developing medical treatments using stem cells
|
|
|
|
|
Today:
1-month:
All-time:
|
+4.9%
+7.7%
+15.8%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+4.8%
+0.2%
-5.2%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$115.9M
0.0
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ASTM |
$0.57 |
-0.01 |
-2.0% |
145,888 |
53% |
$25.6M |
- |
10% |
-76% |
1 Alert (0 News) - View
|
|
|
| ATHX |
$1.86 |
-0.07 |
-3.6% |
356,630 |
33% |
$104.9M |
- |
96% |
-23% |
1 Alert (0 News) - View
|
|
|
| BTX |
$4.19 |
+0.27 |
+6.9% |
197,105 |
149% |
$206.0M |
- |
57% |
-17% |
No Alerts/News
|
|
|
| CUR |
$1.43 |
-0.02 |
-1.4% |
690,851 |
122% |
$99.7M |
- |
240% |
-27% |
1 Alert (0 News) - View
|
|
|
| CYTX |
$2.54 |
+0.04 |
+1.6% |
206,642 |
88% |
$167.9M |
- |
25% |
-48% |
1 Alert (0 News) - View
|
|
|
| GERN |
$1.12 |
0.00 |
0.0% |
275,068 |
40% |
$146.0M |
- |
23% |
-63% |
No Alerts/News
|
|
|
| ISCO |
$0.30 |
+0.02 |
+8.3% |
88,392 |
89% |
$31.1M |
- |
86% |
-33% |
1 Alert (0 News) - View
|
|
|
| KOOL |
$0.93 |
+0.06 |
+6.8% |
9,070 |
54% |
$14.3M |
- |
52% |
-35% |
No Alerts/News
|
|
|
| NBS |
$0.58 |
+0.01 |
+2.2% |
423,462 |
30% |
$96.2M |
- |
64% |
-32% |
1 Alert (0 News) - View
|
|
|
| OPXA |
$1.67 |
0.00 |
0.0% |
95,668 |
48% |
$13.3M |
- |
56% |
-68% |
No Alerts/News
|
|
|
| OSIR |
$10.85 |
+0.15 |
+1.4% |
75,195 |
68% |
$352.3M |
- |
97% |
-25% |
1 Alert (0 News) - View
|
|
|
| PSTI |
$3.06 |
+0.06 |
+2.0% |
177,570 |
142% |
$176.0M |
- |
35% |
-39% |
No Alerts/News
|
|
|
| STEM |
$1.86 |
-0.04 |
-2.1% |
387,369 |
104% |
$73.8M |
- |
215% |
-30% |
1 Alert (0 News) - View
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Athersys Reports First Quarter 2013 Results ATHX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 04:13PM from (globenewswire.com) CLEVELAND, May 14, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three
Flag
Post a comment
ThermoGenesis Reports Third Quarter Fiscal 2013 Results KOOL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 04:13PM from (globenewswire.com) RANCHO CORDOVA, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling
Flag
Post a comment
Cytori Reports First Quarter 2013 Business and Financial Results CYTX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:01PM from (www.businesswire.com) Cytori Therapeutics (NASDAQ: CYTX) today reports its first quarter 2013 financial results and provides updates on clinical
Flag
Post a comment
ThermoGenesis Announces Registration Approval of AXP in China KOOL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 04:13PM from (globenewswire.com) RANCHO CORDOVA, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling
Flag
Post a comment
Osiris Therapeutics Announces First Quarter 2013 Financial Results OSIR
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 08:00AM from (www.businesswire.com) Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat
Flag
Post a comment
Aastrom to Host First Quarter 2013 Investor Call on May 8, 2013 ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 04:13PM from (globenewswire.com) ANN ARBOR, Mich., May 3, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,
Flag
Post a comment
Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call OSIR
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 05:00PM from (www.businesswire.com) Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the first quarter
Flag
Post a comment
Aastrom to Hold Annual Meeting of Shareholders on May 2, 2013 ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 25, 04:43PM from (globenewswire.com) ANN ARBOR, Mich., April 25, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific
Flag
Post a comment
Athersys to Present at 12th Annual Needham Healthcare Conference ATHX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 25, 04:43PM from (globenewswire.com) CLEVELAND, April 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Gil Van Bokkelen, Ph.D.,
Flag
Post a comment
Aastrom Biosciences Announces First Patients Treated in ixCELL-DCM Clinical Study of ixmyelocel-T ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 19, 09:13AM from (globenewswire.com) ANN ARBOR, Mich., April 19, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific
Flag
Post a comment
Athersys to Host First Quarter 2013 Financial Results Call ATHX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 18, 10:43AM from (globenewswire.com) CLEVELAND, April 18, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter
Flag
Post a comment
|
|
|